Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Neurobiol Dis

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    August 2018
  1. GOETZ L, Piallat B, Bhattacharjee M, Mathieu H, et al
    Spike discharge characteristic of the caudal mesencephalic reticular formation and pedunculopontine nucleus in MPTP-induced primate model of Parkinson disease.
    Neurobiol Dis. 2018 Aug 4. pii: S0969-9961(18)30394.
    PubMed     Text format     Abstract available


    June 2018
  2. THEVATHASAN W, Moro E
    What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease?
    Neurobiol Dis. 2018 Jun 19. pii: S0969-9961(18)30193.
    PubMed     Text format     Abstract available


  3. TINKHAUSER G, Torrecillos F, Duclos Y, Tan H, et al
    Beta burst coupling across the motor circuit in Parkinson's disease.
    Neurobiol Dis. 2018 Jun 14. pii: S0969-9961(18)30182.
    PubMed     Text format     Abstract available


  4. TOZZI A, Durante V, Bastioli G, Mazzocchetti P, et al
    Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
    Neurobiol Dis. 2018 Jun 13. pii: S0969-9961(18)30185.
    PubMed     Text format     Abstract available


    May 2018
  5. POLAR CA, Gupta R, Lehmkuhle MJ, Dorval AD, et al
    Correlation between cortical beta power and gait speed is suppressed in a parkinsonian model, but restored by therapeutic deep brain stimulation.
    Neurobiol Dis. 2018 May 30. pii: S0969-9961(18)30151.
    PubMed     Text format     Abstract available


    April 2018
  6. PAN PY, Zhu Y, Shen Y, Yue Z, et al
    Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease.
    Neurobiol Dis. 2018 Apr 30. pii: S0969-9961(18)30136.
    PubMed     Text format     Abstract available


  7. WANG H, Atik A, Stewart T, Ginghina C, et al
    Plasma alpha-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study.
    Neurobiol Dis. 2018 Apr 26. pii: S0969-9961(18)30123.
    PubMed     Text format     Abstract available


  8. ANDERSEN MA, Christensen KV, Badolo L, Smith GP, et al
    Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-alpha-synuclein is normalized by LRRK2 modulation.
    Neurobiol Dis. 2018 Apr 19. pii: S0969-9961(18)30119.
    PubMed     Text format     Abstract available


  9. DE MIRANDA BR, Rocha EM, Bai Q, El Ayadi A, et al
    Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    Neurobiol Dis. 2018 Apr 9. pii: S0969-9961(18)30116.
    PubMed     Text format     Abstract available


    March 2018
  10. GLEAVE JA, Arathoon LR, Trinh D, Lizal KE, et al
    Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146].
    Neurobiol Dis. 2018 Mar 20. pii: S0969-9961(18)30054.
    PubMed     Text format    


  11. PITCAIRN C, Wani WY, Mazzulli JR
    Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.
    Neurobiol Dis. 2018 Mar 14. pii: S0969-9961(18)30074.
    PubMed     Text format     Abstract available


  12. PUSKA G, Lutz MI, Molnar K, Regelsberger G, et al
    Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Neurobiol Dis. 2018 Mar 2. pii: S0969-9961(18)30061.
    PubMed     Text format     Abstract available


    February 2018
  13. RIZZI N, Brunialti E, Cerri S, Cermisoni G, et al
    In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30037.
    PubMed     Text format     Abstract available


  14. PIERCE SE, Tyson T, Booms A, Prahl J, et al
    Parkinson's disease genetic risk in a midbrain neuronal cell line.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30039.
    PubMed     Text format     Abstract available


  15. WU HM, Li T, Wang ZF, Huang SS, et al
    Mitochondrial DNA variants modulate genetic susceptibility to Parkinson's disease in Han Chinese.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30047.
    PubMed     Text format     Abstract available


    January 2018
  16. ALCALAY RN, Wolf P, Levy OA, Kang UJ, et al
    Alpha galactosidase A activity in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 21. pii: S0969-9961(18)30018.
    PubMed     Text format     Abstract available


  17. MERCADO G, Castillo V, Soto P, Lopez N, et al
    Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.
    Neurobiol Dis. 2018 Jan 17. pii: S0969-9961(18)30004.
    PubMed     Text format     Abstract available


  18. SHAROTT A, Gulberti A, Hamel W, Koppen JA, et al
    Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 4. pii: S0969-9961(18)30001.
    PubMed     Text format     Abstract available


  19. ALDRIN-KIRK P, Heuer A, Rylander Ottosson D, Davidsson M, et al
    Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
    Neurobiol Dis. 2018;109.
    PubMed     Text format     Abstract available


    December 2017
  20. NELSON MP, Boutin M, Tse TE, Lu H, et al
    The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.
    Neurobiol Dis. 2017;110:68-81.
    PubMed     Text format     Abstract available


    October 2017
  21. SPIGOLON G, Cavaccini A, Trusel M, Tonini R, et al
    cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease.
    Neurobiol Dis. 2017 Oct 28. pii: S0969-9961(17)30243.
    PubMed     Text format     Abstract available


    September 2017
  22. SYRKIN-NIKOLAU J, Koop MM, Prieto T, Anidi C, et al
    Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease.
    Neurobiol Dis. 2017 Sep 7. pii: S0969-9961(17)30214.
    PubMed     Text format     Abstract available


    August 2017
  23. BIOSA A, Sandrelli F, Beltramini M, Greggio E, et al
    Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease.
    Neurobiol Dis. 2017 Aug 17. pii: S0969-9961(17)30186.
    PubMed     Text format     Abstract available


    July 2017
  24. RYDBIRK R, Elfving B, Andersen MD, Langbol MA, et al
    Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients.
    Neurobiol Dis. 2017;106:269-278.
    PubMed     Text format     Abstract available


    June 2017
  25. ARATHOON LR, Gleave JA, Trinh D, Lizal KE, et al
    Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism.
    Neurobiol Dis. 2017 Jun 30. pii: S0969-9961(17)30136.
    PubMed     Text format     Abstract available


    May 2017
  26. GIESERT F, Glasl L, Zimprich A, Ernst L, et al
    The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
    Neurobiol Dis. 2017 May 30. pii: S0969-9961(17)30123.
    PubMed     Text format     Abstract available


    April 2017
  27. JULIENNE H, Buhl E, Leslie DS, Hodge JJL, et al
    Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.
    Neurobiol Dis. 2017 Apr 20. pii: S0969-9961(17)30088.
    PubMed     Text format     Abstract available


  28. CAVALIERE F, Cerf L, Dehay B, Ramos-Gonzalez P, et al
    In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.
    Neurobiol Dis. 2017;103:101-112.
    PubMed     Text format     Abstract available


  29. ROCHA EM, De Miranda B, Sanders LH
    Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Neurobiol Dis. 2017 Apr 8. pii: S0969-9961(17)30080.
    PubMed     Text format     Abstract available


    March 2017
  30. LALOUX C, Gouel F, Lachaud C, Timmerman K, et al
    Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?
    Neurobiol Dis. 2017 Mar 28. pii: S0969-9961(17)30061.
    PubMed     Text format     Abstract available


    December 2016
  31. SONG L, McMackin M, Nguyen A, Cortopassi G, et al
    Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30314.
    PubMed     Text format     Abstract available


  32. MASILAMONI GJ, Groover O, Smith Y
    Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30315.
    PubMed     Text format     Abstract available


  33. VAINE CA, Shin D, Liu C, Hendriks W, et al
    X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Neurobiol Dis. 2016 Dec 22. pii: S0969-9961(16)30299.
    PubMed     Text format     Abstract available


  34. GENG X, Zhang J, Jiang Y, Ashkan K, et al
    Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.
    Neurobiol Dis. 2016;98:100-107.
    PubMed     Text format     Abstract available


  35. KOZINA EA, Kim AR, Kurina AY, Ugrumov MV, et al
    Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Neurobiol Dis. 2016;98:108-121.
    PubMed     Text format     Abstract available


    September 2016
  36. NKILIZA A, Mutez E, Simonin C, Lepretre F, et al
    RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.
    Neurobiol Dis. 2016 Sep 20. pii: S0969-9961(16)30230.
    PubMed     Text format     Abstract available


  37. KIRIK D, Cederfjall E, Halliday G, Petersen A, et al
    Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands.
    Neurobiol Dis. 2016 Sep 8. pii: S0969-9961(16)30222.
    PubMed     Text format     Abstract available


    August 2016
  38. TRAGER MH, Koop MM, Velisar A, Blumenfeld Z, et al
    Subthalamic Beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Neurobiol Dis. 2016 Aug 20. pii: S0969-9961(16)30201.
    PubMed     Text format     Abstract available


    July 2016
  39. RUNEBERG-ROOS P, Piccinini E, Penttinen AM, Matlik K, et al
    Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease.
    Neurobiol Dis. 2016 Jul 14. pii: S0969-9961(16)30167.
    PubMed     Text format     Abstract available


  40. PETRYSZYN S, Di Paolo T, Parent A, Parent M, et al
    The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys.
    Neurobiol Dis. 2016 Jul 4. pii: S0969-9961(16)30159.
    PubMed     Text format     Abstract available


    June 2016
  41. PADEL T, Ozen I, Boix J, Barbariga M, et al
    Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease.
    Neurobiol Dis. 2016 Jun 7. pii: S0969-9961(16)30135.
    PubMed     Text format     Abstract available


    May 2016
  42. PODLESNIY P, Vilas D, Taylor P, Shaw LM, et al
    Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease.
    Neurobiol Dis. 2016;94:10-17.
    PubMed     Text format     Abstract available


  43. DO VAN B, Gouel F, Jonneaux A, Timmerman K, et al
    Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.
    Neurobiol Dis. 2016 May 14. pii: S0969-9961(16)30105.
    PubMed     Text format     Abstract available


  44. SIDDIQUI A, Rane A, Rajagopalan S, Chinta SJ, et al
    Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
    Neurobiol Dis. 2016 May 13. pii: S0969-9961(16)30103.
    PubMed     Text format     Abstract available


  45. GORDON R, Singh N, Lawana V, Ghosh A, et al
    Protein kinase Cdelta upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Neurobiol Dis. 2016 May 2. pii: S0969-9961(16)30090.
    PubMed     Text format     Abstract available


    April 2016
  46. MATZNER A, Moran A, Erez Y, Tischler H, et al
    Beta oscillations in the parkinsonian primate: Similar oscillations across different populations.
    Neurobiol Dis. 2016 Apr 12. pii: S0969-9961(16)30076.
    PubMed     Text format     Abstract available


    March 2016
  47. PEREZ-ORTEGA J, Duhne M, Lara-Gonzalez E, Plata V, et al
    Pathophysiological signatures of functional connectomics in parkinsonian and dyskinetic striatal microcircuits.
    Neurobiol Dis. 2016 Mar 4. pii: S0969-9961(16)30043.
    PubMed     Text format     Abstract available


    February 2016
  48. SANTORO M, Maetzler W, Stathakos P, Martin HL, et al
    In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.
    Neurobiol Dis. 2016 Feb 24. pii: S0969-9961(16)30040.
    PubMed     Text format     Abstract available


  49. WANG DD, de Hemptinne C, Miocinovic S, Qasim SE, et al
    Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Neurobiol Dis. 2016 Feb 13. pii: S0969-9961(16)30036.
    PubMed     Text format     Abstract available


  50. PARK HY, Ryu YK, Kim YH, Park TS, et al
    Gadd45beta ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model.
    Neurobiol Dis. 2016 Feb 10. pii: S0969-9961(16)30034.
    PubMed     Text format     Abstract available


    January 2016
  51. ARCURI L, Viaro R, Bido S, Longo F, et al
    Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.
    Neurobiol Dis. 2016 Jan 21. pii: S0969-9961(16)30016.
    PubMed     Text format     Abstract available


    December 2015
  52. MACHADO V, Haas SJ, von Bohlen Und Halbach O, Wree A, et al
    Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson s disease.
    Neurobiol Dis. 2015 Dec 27. pii: S0969-9961(15)30118.
    PubMed     Text format     Abstract available


    November 2015
  53. QASIM SE, de Hemptinne C, Swann NC, Miocinovic S, et al
    Electrocorticography reveals beta desynchronization in the basal ganglia-cortical loop during rest tremor in Parkinson's disease.
    Neurobiol Dis. 2015 Nov 27. pii: S0969-9961(15)30101.
    PubMed     Text format     Abstract available


  54. DUPRE KB, Cruz AV, McCoy AJ, Delaville C, et al
    Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Neurobiol Dis. 2015 Nov 13. pii: S0969-9961(15)30088.
    PubMed     Text format     Abstract available


  55. VON STOCKUM S, Nardin A, Schrepfer E, Ziviani E, et al
    Mitochondrial dynamics and mitophagy in Parkinson's disease: A fly point of view.
    Neurobiol Dis. 2015 Nov 6. pii: S0969-9961(15)30081.
    PubMed     Text format     Abstract available


    October 2015
  56. KOHL Z, Abdallah NB, Vogelgsang J, Tischer L, et al
    Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC alpha-synuclein transgenic rat model of Parkinson's disease.
    Neurobiol Dis. 2015 Oct 30. pii: S0969-9961(15)30079.
    PubMed     Text format     Abstract available


  57. DUVAL C, Daneault JF, Hutchison WD, Sadikot AF, et al
    A brain network model explaining tremor in Parkinson's disease.
    Neurobiol Dis. 2015 Oct 9. pii: S0969-9961(15)30065.
    PubMed     Text format     Abstract available


    August 2015
  58. CENCI MA, Francardo V, O'Sullivan SS, Lindgren HS, et al
    Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
    Neurobiol Dis. 2015 Aug 29. pii: S0969-9961(15)30046.
    PubMed     Text format     Abstract available


    July 2015
  59. STAVARACHE MA, Musatov S, McGill M, Vernov M, et al
    The Tumor Suppressor PTEN Regulates Motor Responses to Striatal Dopamine in Normal and Parkinsonian Animals.
    Neurobiol Dis. 2015 Jul 29. pii: S0969-9961(15)30017.
    PubMed     Text format     Abstract available


  60. CISBANI G, Drouin-Ouellet J, Gibrat C, Saint-Pierre M, et al
    Cystamine/cysteamine rescue the dopaminergic system and show neurorestorative properties in an animal model of Parkinson's disease.
    Neurobiol Dis. 2015 Jul 29. pii: S0969-9961(15)30015.
    PubMed     Text format     Abstract available


  61. TAGLIAFERRO P, Kareva T, Oo TF, Yarygina O, et al
    An Early Axonopathy in a hLRRK2(R1441G) Transgenic Model of Parkinson Disease.
    Neurobiol Dis. 2015 Jul 17. pii: S0969-9961(15)30013.
    PubMed     Text format     Abstract available


  62. VAIKATH NN, Majbour NK, Paleologou KE, Ardah MT, et al
    Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology.
    Neurobiol Dis. 2015;79:81-99.
    PubMed     Text format     Abstract available


    June 2015
  63. JENNINGS KA, Platt NJ, Cragg SJ
    The impact of a parkinsonian lesion on dynamic striatal dopamine transmission depends on nicotinic receptor activation.
    Neurobiol Dis. 2015 Jun 25. pii: S0969-9961(15)00233.
    PubMed     Text format     Abstract available


  64. TONG J, Ang LC, Williams B, Furukawa Y, et al
    Low Levels of Astroglial Markers in Parkinson's Disease: Relationship to alpha-Synuclein Accumulation.
    Neurobiol Dis. 2015 Jun 20. pii: S0969-9961(15)00228.
    PubMed     Text format     Abstract available


  65. WU T, Hallett M, Chan P
    Motor Automaticity in Parkinson's Disease.
    Neurobiol Dis. 2015 Jun 20. pii: S0969-9961(15)00232.
    PubMed     Text format     Abstract available


  66. AMBROSI G, Ghezzi C, Zangaglia R, Levandis G, et al
    Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.
    Neurobiol Dis. 2015 Jun 18. pii: S0969-9961(15)00226.
    PubMed     Text format     Abstract available


  67. FREMONT R, Tewari A, Khodakhah K
    Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism.
    Neurobiol Dis. 2015 Jun 17. pii: S0969-9961(15)00222.
    PubMed     Text format     Abstract available


  68. COTE M, Bourque M, Poirier AA, Aube B, et al
    GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of parkinson's disease.
    Neurobiol Dis. 2015 Jun 4. pii: S0969-9961(15)00191.
    PubMed     Text format     Abstract available


    May 2015
  69. COLLIER TJ, O'Malley J, Rademacher DJ, Stancati JA, et al
    Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.
    Neurobiol Dis. 2015;77:191-203.
    PubMed     Text format     Abstract available


    April 2015
  70. LIM SA, Xia R, Ding Y, Won L, et al
    Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.
    Neurobiol Dis. 2015;76:67-76.
    PubMed     Text format     Abstract available


    January 2015
  71. SOLIS O, Espadas I, Del-Bel EA, Moratalla R, et al
    Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
    Neurobiol Dis. 2015;73:49-59.
    PubMed     Text format     Abstract available


    August 2014
  72. CHOU JS, Chen CY, Chen YL, Weng YH, et al
    (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.
    Neurobiol Dis. 2014;68:190-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: